Insulin and glucagon are critical hormones in metabolic regulation.
-
Their physiology extends beyond simple blood glucose control.
-
Numerous other hormones influence glucose homeostasis (cortisol, epinephrine, incretins, etc.).
-
Modern medicine continues to refine understanding of their complex roles.
Pancreas – Anatomy & Histology
Macroscopic structure:
-
Located in upper abdomen, posterior to stomach.
-
Divided into head, body, and tail.
-
Ducts:
-
Main pancreatic duct (joins common bile duct → ampulla of Vater).
-
Accessory duct in minority of people (minimal clinical relevance).
-
Microscopic structure:
-
Two functional components:
-
Exocrine (acini) → digestive enzyme secretion into duodenum.
-
Endocrine (islets of Langerhans):
-
α-cells → glucagon
-
β-cells → insulin + amylin
-
δ-cells → somatostatin
-
γ (PP) cells → pancreatic polypeptide
-
ε-cells → ghrelin
-
-
Insulin vs Glucagon – Core Actions
Insulin (fed state):
-
Promotes storage and utilization of nutrients.
-
↑ Glycolysis (glucose utilization)
-
↑ Glycogenesis (glycogen storage)
-
↑ Lipogenesis (fat storage)
-
↑ Protein synthesis
-
↑ Glucose uptake in tissues
Glucagon (fasting state):
-
Promotes mobilization and generation of fuel.
-
↑ Gluconeogenesis (new glucose synthesis)
-
↑ Glycogenolysis (glycogen breakdown)
-
↑ Lipolysis + β-oxidation (fat breakdown)
-
↑ Proteolysis (protein breakdown)
-
↑ Ketogenesis (ketone body production)
Key point: They act antagonistically to maintain normal blood glucose levels.
Major Target Tissues
-
Liver
-
Insulin: ↑ glycogen, ↑ triglycerides, ↑ fatty acid synthesis.
-
Glucagon: ↑ glycogen breakdown, ↑ gluconeogenesis, ↑ ketogenesis.
-
-
Skeletal Muscle
-
Insulin: ↑ glucose & amino acid uptake, ↑ protein synthesis, ↑ glycogen.
-
Glucagon: indirect effects (mobilizes substrates).
-
-
Adipose Tissue
-
Insulin: ↑ fatty acid uptake, ↑ triglyceride storage (lipogenesis).
-
Glucagon: ↑ lipolysis → free fatty acids for fuel.
-
Additional Hormones in Glucose Homeostasis
Pancreatic hormones:
-
Amylin (β-cells): slows gastric emptying, promotes satiety, suppresses glucagon.
-
Somatostatin (δ-cells): inhibits insulin & glucagon; slows GI motility.
Gut hormones (Incretins):
-
GIP (K-cells, duodenum/jejunum): stimulates insulin secretion.
-
GLP-1 (L-cells, ileum/colon): ↑ insulin, ↓ glucagon, slows gastric emptying, ↑ satiety.
-
Both inactivated by DPP-4 enzyme → therapeutic target (DPP-4 inhibitors in diabetes).
Counter-regulatory stress hormones:
-
Cortisol, Epinephrine, Growth Hormone → oppose insulin.
-
Net effects: ↓ insulin secretion, ↑ gluconeogenesis, ↑ lipolysis, ↓ glucose uptake → hyperglycemia.
Insulin Synthesis & Structure
-
Insulin = two chains (A & B) linked by disulfide bonds.
-
Synthesis steps:
-
Preproinsulin synthesized (with signal peptide).
-
Signal peptide removed → Proinsulin.
-
Disulfide bridges form between A and B chains.
-
C-peptide (connecting peptide) cleaved → active Insulin + C-peptide.
-
Clinical relevance:
-
C-peptide is secreted equimolarly with insulin.
-
Used to distinguish:
-
Endogenous insulin excess (e.g., insulinoma) → high C-peptide.
-
Exogenous insulin administration → low C-peptide.
-
Temporal Relationship of Glucose Sources
-
Fed state (0–6 hrs after meal):
-
Insulin dominates.
-
Glucose primarily from dietary intake.
-
-
Early fasting (6–24 hrs):
-
Glucagon increases.
-
Primary glucose source = glycogenolysis.
-
-
Prolonged fasting/starvation (>24 hrs):
-
Glycogen stores depleted.
-
Gluconeogenesis becomes primary glucose source (amino acids, glycerol, lactate).
-
Ketone bodies & fatty acids provide alternative fuel.
-
Key Clinical Takeaways
-
Insulin and glucagon work in dynamic opposition to regulate fuel availability.
-
Regulation involves multiple additional hormones (incretins, stress hormones, pancreatic peptides).
-
C-peptide is an important clinical marker for endogenous vs exogenous insulin.
-
In fasting → glycogenolysis, then gluconeogenesis + ketogenesis maintain energy supply.
No comments:
Post a Comment